Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial
Beijing Xisike Clinical Oncology Research Foundation
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial
Meng Qiu, Peng Cao, Zhenpeng Wen, Han Wang et al.
Journal
BMC Cancer
Topics
Colorectal Cancer Treatments and Studies
article
Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial
Meng Qiu, Peng Cao, Zhenpeng Wen, Han Wang, Jiyan Liu, Weibing Leng, Deyun Luo
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Funders
Beijing Xisike Clinical Oncology Research Foundation